Skadden Arps Slate Meagher & Flom LLP | USA | 24 May 2022
Earlier this year the United States Courts of Appeals for the Seventh and Ninth Circuits each addressed the question of whether an exclusive forum…
Kurtin PLLC | USA | 16 May 2022
This is the third of a series of periodically issued advisories on Mergers & Acquisitions (M&A) that we started in April 2022. Its predecessors in…
Kurtin PLLC | USA | 4 May 2022
This is the second of a series of periodically issued advisories on Mergers and Acquisitions (M&A) that we started in April 2022. Like the first in…
Hogan Lovells | USA | 25 Apr 2022
In In re Forum Mobile, Inc., C.A. No. 2020-0346-JTL (Del. Ch. Feb. 3, 2022), the Delaware Chancery Court held that Section 226(a)(3) of the Delaware…
Skadden Arps Slate Meagher & Flom LLP | USA | 19 Apr 2022
On March 22, 2022, Skadden hosted a webinar on recent developments in Delaware corporate law. Litigation partners Edward Micheletti and Jenness Parker…
Skadden Arps Slate Meagher & Flom LLP | USA | 18 Apr 2022
On April 12, 2022, the Corporation Law Section of the Delaware State Bar Association (DSBA) approved proposed amendments to the Delaware General…
Skadden Arps Slate Meagher & Flom LLP | USA | 9 Feb 2022
On February 7, 2022, Delaware’s governor signed a bill amending the Delaware General Corporation Law (DGCL) to expressly authorize Delaware…
Skadden Arps Slate Meagher & Flom LLP | USA | 25 Jun 2021
The Delaware Supreme Court has issued two decisions over the past year that provide important guidance about directors’ and officers’ (D&O) liability…
Skadden Arps Slate Meagher & Flom LLP | USA | 26 Jan 2021
The Delaware Court of Chancery’s docket exploded with expedited “broken” deal litigation in 2020, driven by the impact of COVID-19. Beyond…
Hogan Lovells | USA | 24 Nov 2020
In 2001, Gilead received FDA approval for a life-saving HIV drug, Viread® (tenofovir disoproxil fumarate (TDF)). In late 2019 and early 2020, four…